医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

1型糖尿病患者糖化白蛋白/HbA 1C比值与血糖波动幅度及长期血糖控制的相关研究

Correlation study on glycated albumin to glycated hemoglobin ratio and amplitude of glucose excursions and long-term glycemic control in type 1 diabetic patients

摘要目的:探讨1型糖尿病人群中糖化白蛋白/HbA 1C比值与血糖波动幅度的相关性及基线糖化白蛋白/HbA 1C比值与长期血糖控制的相关性。 方法:2013年至2014年于复旦大学附属中山医院首诊的1型糖尿病住院患者共110例入选。收集其一般临床资料,包括基线空腹C肽、激发后C肽(精氨酸试验),基线及2017年至2018年期间随访时HbA 1C、糖化白蛋白(GA)、空腹血糖等,采集每例患者胰岛素皮下注射1周后3日的每日7次指尖血糖(包括三餐前、三餐后2 h及睡前)值,并以此计算平均血糖、平均血糖波动幅度(MAGE)、最高及最低血糖差在内的血糖波动指数。采用SPSS 13.0统计学软件进行数据统计分析。 结果:110例1型糖尿病患者以基线GA/HbA 1C比值三分位数分组,随着基线GA/HbA 1C比值升高,基线空腹C肽和激发后C肽值呈逐渐降低趋势( P趋势<0.05),基线MAGE、随访时HbA 1C和空腹血糖呈逐步升高趋势( P趋势<0.05)。 Pearson相关分析显示,基线GA/HbA 1C比值与基线空腹C肽和激发后C肽水平呈负相关( P<0.01),与基线MAGE及随访时HbA 1C和空腹血糖呈正相关( P<0.05)。多元线性逐步回归分析显示,基线GA/HbA 1C比值与基线MAGE和激发后C肽水平、随访时空腹血糖和HbA 1C独立相关( P<0.05)。多因素 COX回归分析显示,基线GA/HbA 1C比值大于2.85是随访时空腹血糖( OR=3.028,95% CI 1.291~7.101)、HbA 1C( OR=3.038,95% CI 1.416~6.515)不达标的独立危险因素。 结论:1型糖尿病患者基线GA/HbA 1C与血糖波动幅度切相关,与随访后的空腹血糖和HbA 1C独立相关,基线GA/HbA 1C比值大于2.85是空腹血糖及HbA 1C不达标的独立危险因素。

更多

abstractsObjective:The relationships between glycated albumin(GA) to HbA 1C ratio and the blood glucose variability, and the correlations between baseline GA to HbA 1C ratio and long-term glycemic control in type 1 diabetic patients were investigated. Methods:One hundred and ten patients with new-onset type 1 diabetes from Zhongshan Hospital, Fudan University were recruited during 2013-2014. Relevant clinical data, including fasting and stimulated C-peptide(arginine stimulation test) at baseline, HbA 1C, GA, fasting blood glucose at baseline and follow-up during 2017-2018 were collected. Capillary glucose values of each patient were recorded 7 times daily(preprandial and 120 minutes postprandial for each meal and bedtime)for 3 days after 1 week of subcutaneous injection of insulin. The blood glucose fluctuation indexes, including mean blood glucose, mean amplitude of glucose excursions(MAGE), △blood glucose were calculated. The software SPSS 13.0 was used for the statistical analysis. Results:One hundred and ten patients with type 1 diabetes were grouped by baseline GA/HbA 1C ratio tertiles. With the increasing of GA/HbA 1C at baseline, the fasting and stimulated C-peptide at baseline were gradually decreased( Ptrend<0.05); MAGE at baseline, HbA 1C and fasting blood glucose after follow-up increased gradually( Ptrend<0.05). Pearson correlation analysis showed that the baseline GA/HbA 1C ratio was negatively correlated with fasting and stimulated C-peptide at baseline( P<0.01), and positively correlated with MAGE at baseline, HbA 1C and fasting blood glucose after follow-up( P<0.05). Stepwise multivariate analysis suggested that the baseline GA/HbA 1C ratio was independently associated with MAGE and stimulated C-peptide at baseline, fasting blood glucose and HbA 1C after follow-up( P<0.05). Multivariate COX regression analysis showed that baseline GA/HbA 1C ratio greater than 2.85 acted as an independent risk factor for un-controlled fasting blood glucose( OR=3.028, 95% CI 1.291-7.101)and HbA 1C( OR=3.038, 95% CI 1.416-6.515) after follow-up. Conclusion:Baseline GA/HbA 1C was closely associated with glucose excursion in type 1 diabetes patients, and was independently associated with fasting blood glucose and HbA 1C after follow-up. Baseline GA/HbA 1C ratio greater than 2.85 was an independent risk factor for un-controlled fasting blood glucose, as well as HbA 1C.

More
广告
作者 王柏荣 [1] 徐晶 [1] 李晓牧 [1] 学术成果认领
作者单位 复旦大学附属中山医院内分泌科,上海 200032(现在福建省晋江市医院内分泌科 362200) [1]
栏目名称
DOI 10.3760/cma.j.cn311282-20200120-00036
发布时间 2026-01-13(万方平台首次上网日期,不代表论文的发表时间)
基金项目
国家自然科学基金面上项目(81970695、81770770); National Natural Science Foundation of China(81970695, 81770770)
  • 浏览324
  • 下载215
中华内分泌代谢杂志

中华内分泌代谢杂志

2020年36卷12期

1027-1031页

ISTICPKUCSCDCA

加载中!

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

扩展文献

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷